Highlights from the Movement Disorder Society Virtual Congress 2021

  Every year the International Parkinson and Movement Disorder Society (MDS) holds a conference and every year APDA is there, learning about the newest research and sharing our resources with the wider Parkinson’s disease (PD) community. The MDS Congress is the preeminent gathering of medical professionals from around the world who are dedicated to PD […]

Read More

APDA funding is critical to new research in understanding Levodopa-induced dyskinesias

In an exciting new study, researchers at the Graduate Center, City University of New York (CUNY) and the CUNY School of Medicine, led by Dr. Andreas Kottmann, studied levodopa induced dyskinesias (LIDs) and demonstrated that inhibiting a protein called sonic hedgehog (Shh) decreased LIDs in animal models of PD. The study appears today in Communications […]

Read More

PARKINSON’S DISEASE IN A POST-PANDEMIC WORLD: WHAT’S NEXT?

PARKINSON’S DISEASE IN A POST-PANDEMIC WORLD: WHAT’S NEXT? Vaccination rates against COVID-19 are on the rise and reaching promising levels across the nation. A return to “normal” is something we’ve all been looking forward to, and we hope to continue to head in that direction even as variants emerge and give us pause. As more […]

Read More

Pushing for Progress: American Parkinson Disease Association Funding To Accelerate Scientists’ Pursuit for Answers

Pushing for Progress: American Parkinson Disease Association Funding To Accelerate Scientists’ Pursuit for Answers From biomarker development to the use of sono-optogenetics, $1.85 million in innovative research to be funded for 2021– 2022 year NEW YORK, NY, September 1, 2021 – The American Parkinson Disease Association (APDA) has just awarded $1.85 million to support cutting-edge […]

Read More